SMS Lifesciences gets zero USFDA observations for Kazipally facility

Published On 2022-04-11 06:22 GMT   |   Update On 2022-04-11 06:22 GMT
Advertisement

Telangana: SMS Lifesciences India has recently announced that the United States Food and Drug Administration (USFDA) has concluded an inspection with zero observations at its API's manufacturing facility located at Kazipally, Jinnaram MandaI, Sangareddy district, Telangana (Unit I ).

"We are glad to inform you that the Company has completed the United States Food and Drug Administration (USFDA) inspection at its API' s manufacturing facility located at Sy. NO.180/2, Kazipally, Jinnaram MandaI, Sangareddy district, Telangana (Unit I ), without any observations," the company said in a BSE filing.  

Advertisement

The inspection commenced on 04.04.2022 and concluded on 08.04.2022.

Read also: USFDA okays Alembic Pharma Dabigatran Etexilate Capsules

SMS Lifesciences is a global player in APIs/Intermediates manufacturing having a research and manufacturing team supported by state-of-the-art facilities. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having products spread across an array of therapeutic segments. SMS Group was given the export house status in the year 1997-98. 

Having three multi-product facilities in operation and a research centre, SMS Lifesciences executed contract manufacturing and research assignment for the global customer base. The company has won accolades like the "India Pharma Bulk Drug Company of the Year Award" from the Government of India in 2020 and the "Outstanding Export Performance Award 2018-19" in the "All round-Rising Star" Category from The Pharmaceuticals Export Promotion Council of India.

Read also: Indoco Remedies bags USFDA nod for Lacosamide Injection

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News